‘High-Profile and HIV+’ Revives Ethical Questions

Screenshot 2015-11-18 10.16.08

This piece was originally published yesterday on
the Fordham News blog

By: Gina Vergel

Actor Charlie Sheen made headlines in 2011 with a number of trips to rehab, his dismissal from hit show Two and a Half Men, and a public meltdown.

Four years later, he’s back in the news, as he revealed he is HIV positive in a TODAY interview with Matt Lauer.

“It’s a hard three letters to absorb. It’s a turning point in one’s life,” the 50-year-old actor said to Lauer.

Human immunodeficiency virus, or HIV, is living inside the bodies of an estimated 35 million people worldwide. In the United States, 1.2 million people are living with HIV and the U.S. fails to prevent about another 50,000 infections every year. (source)

What does this high profile celebrity having HIV mean for the stigma often associated with the virus, or how the public is educated on the disease?

Fordham’s Celia Fisher, PhD, the director of both Fordham’s Center for Ethics Education and the HIV and Drug Abuse Prevention Research Ethics Training Institute, said a lot has changed since 1991, when NBA great Magic Johnson announced he was HIV positive.

“For those in countries where medication is widely available becoming HIV positive has become a chronic disease, rather than a death sentence on a path towards AIDS,” she said. “The risk of becoming infected has also been reduced through HIV prevention medications such as PrEP (Pre-Exposure Prophylaxis) that can prevent the acquisition of HIV, as well as evidence that taking certain HIV medications can lessen the risk of further transmission. There is also growing interest in using emerging technologies for HIV prevention, such as mobile health text reminders to take medication and the use of social media to increase HIV health literacy.”

Despite these medical gains, Fisher said, sexual and gender minority youth in the United States, and women in countries with extreme gender inequities and other marginalized populations, do not have access to these treatments.

“These inequities raise ethical challenges for public health policy makers, health providers, and medical and social behavioral researchers,” Fisher said. “The Fordham University HIV and Drug Abuse Prevention Research Ethics Training Institute is dedicated to training researchers how to uncover and address the causes of these inequities to create an AIDS-free world.”

To learn more about the hard data generated by the HIV and Drug Abuse Prevention Research Ethics Training Institute at Fordham—the only one of its kind, read this piece from last November.

For more information on HIV, see this article by Fordham alumnus, Mathew Rodriguez (FCLC ’11), in Mic.

Please visit the Fordham News blog for the original post.

The Fordham University HIV and Drug Abuse Prevention Research Ethics Training Institute is now accepting applications for the 2016 Summer Institute. Please visit our website or contact Dr. Elizabeth Yuko (ethicsinst@fordham.edu) for more information. The deadline for applications is February 25, 2016. 


3 thoughts on “‘High-Profile and HIV+’ Revives Ethical Questions

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s